Filing Details

Accession Number:
0000899243-15-008442
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-18 19:29:15
Reporting Period:
2015-08-14
Filing Date:
2015-11-18
Accepted Time:
2015-11-18 19:29:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631574 Wave Life Sciences Ltd. WVE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657769 Partnership Limited Investment Sousei Shinsangyo Kagoshima 6-1-20, Nanei, Kagoshima City
Kagoshima M0 891-0122
No No Yes No
1657771 Masaharu Tanaka C/O Kagoshima Shinsangyo Sousei Invest.
Ltd. P., 6-1-20, Nanei, Kagoshima City
Kagoshima M0 891-0122
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-11-16 161,663 $0.00 3,152,440 No 4 C Indirect See Footnote
Ordinary Shares Acquisiton 2015-11-16 76,250 $16.00 3,228,690 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Series B Preferred Shares Acquisiton 2015-08-14 161,663 $12.37 161,663 $0.00
Ordinary Shares Series B Preferred Shares Disposition 2015-11-16 161,663 $0.00 161,663 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
161,663 No 4 P Indirect
0 No 4 C Indirect
Footnotes
  1. The Series B Preferred Shares converted into Ordinary Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of its Ordinary Shares and had no expiration date.
  2. Shares held by Kagoshima Shinsangyo Sousei Investment Limited Partnership ("KSS"). Masaharu Tanaka, a director of the Issuer, is the representative director of Kagoshima Development Co., Ltd., the general partner of KSS and may be deemed to beneficially own the reported securities. Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), Mr. Tanaka disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The filing of this Form 4 shall not be construed as an admission that Mr. Tanaka is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of the reported securities.
  3. Share amounts reflect a 4.0415917-for-1 forward split of the Issuer's shares on November 1, 2015. The securities were purchased for $12.37 per share on a post-split basis.